Literature DB >> 2204730

Penile blood flow changes in the flaccid and erect state in potent young men measured by duplex scanning.

B C Mellinger1, E D Vaughan.   

Abstract

We studied penile blood flow changes with duplex ultrasound scanning in 8 potent young men during the flaccid state and during the erect state induced by visual sexual stimulation. Measured parameters obtained from the cavernous arteries were arterial diameter, peak blood flow velocity and blood flow acceleration. The mean arterial diameter change was 72% associated with average blood flow velocity and acceleration changes of approximately 200%. Actual values for blood flow velocity and acceleration were considerably higher when compared to papaverine-induced values measured in psychogenically impotent men. Visual sexually stimulated penile arterial changes are not analogous to papaverine-induced arterial changes and these differences raise questions about the appropriateness of using psychogenically impotent men as controls for measurement of penile arterial function with duplex scanning.

Entities:  

Mesh:

Year:  1990        PMID: 2204730     DOI: 10.1016/s0022-5347(17)39617-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Correlation between peak systolic velocity and diameter of cavernosal arteries in flaccid versus dynamic state for the evaluation of erectile dysfunction.

Authors:  R Souper; J Hartmann; M Alvarez; I Fuentes; G Astroza; M Marconi
Journal:  Int J Impot Res       Date:  2017-04-06       Impact factor: 2.896

2.  Ultrastructual changes of corpora cavernosa in vascular erectile dysfunction.

Authors:  K Aydos; S Baltaci; M Sağlam; A Tanyolaç; K Anafarta; Y Bedük; O Gögüş
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

3.  Accurate and time-saving, two-step intracavernosal injection procedure to diagnose psychological erectile dysfunction.

Authors:  Daniele Santi; Giorgia Spaggiari; Manuela Simoni; Antonio R M Granata
Journal:  Andrology       Date:  2022-03-21       Impact factor: 4.456

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.